R 1498
Latest Information Update: 14 Mar 2006
At a glance
- Originator Roche
- Class
- Mechanism of Action Cytoplasmic and nuclear receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 31 Dec 2005 No development reported - Preclinical for Type-2 diabetes mellitus in Switzerland (unspecified route)
- 19 Apr 2004 Preclinical trials in Type-2 diabetes mellitus in Switzerland (unspecified route)